Boston, MANCT06202183Now EnrollingIRB Ready

Colorectal Cancer Clinical Trial in Boston, MA

Access cutting-edge colorectal cancer treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.

Sponsored by Dana-Farber Cancer Institute

Quick Self-Assessment

See if you qualify for this Boston location

Preparing your pre-screening questions…

Expert Care in Boston

Access colorectal cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related colorectal cancer treatment provided free

Apply for This Boston Location

Check if you qualify for this colorectal cancer clinical trial in Boston, MA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Boston

    Convenient for MA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Boston site if eligible
  4. 4Begin participation

About This Colorectal Cancer Study in Boston

This research study is a randomized controlled trial that will observe changes in microbiome activity, changes in chemotherapy toxicity, and any changes in treatment outcomes between two groups of participants undergoing chemotherapy with either early-stage or metastatic colorectal cancer. The names of the study groups involved in this study are: * Exercise * Waitlist Control

Sponsor: Dana-Farber Cancer Institute

Who Can Participate

Inclusion Criteria

Patient diagnosed with early-stage or metastatic colon or rectal cancer
Age at diagnosis 18-50 years; due to the specificity of the study question those outside the age bracket will not be included
No plans for major surgical intervention at the time of recruitment for a minimum of 12 weeks (i.e. study period; placement of port a cath is allowed)
No plans for radiation therapy at the time of recruitment for a minimum of 12 weeks
On or planning chemotherapy
Participate in less than or equal to 90 minutes of moderate-to-vigorous exercise per week
Medical clearance to perform exercise intervention and testing by their treating oncologist
No uncontrolled medical conditions that could be exacerbated with exercise
Ability to communicate and complete written forms in English
Ability to understand and the willingness to sign informed consent prior to any study-related procedures
Willing to travel to DFCI for necessary data collection

Exclusion Criteria

Participate in more than 90 minutes of moderate-to-vigorous aerobic exercise per week over the past month. This study targets insufficiently active persons to assess the effect of the described exercise intervention, where additional exercise done regularly will contaminate the intervention effects.
Unstable comorbidities that prevent participation in moderate-to-vigorous intensity exercise. Patients with unstable comorbidities may develop unexpected adverse events from exercise. For the purpose of patients' safety, as well as because this study involves remote, home-based exercise where close supervision is not possible, patients with unstable medical conditions are excluded.
Patients actively on a weigh loss diet and/or actively taking weight loss drugs. This could effect gut microbiome.
Patient with other active malignancies (excluding basal cell carcinoma).
Subjects who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Boston?

Yes, this clinical trial (NCT06202183) has an active research site in Boston, MA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Colorectal Cancer Treatment Options in Boston, MA

If you're searching for colorectal cancer treatment options in Boston, MA, this clinical trial (NCT06202183) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced colorectal cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all colorectal cancer clinical trials near you to find additional studies recruiting in your area.

More Colorectal Cancer Trials in Boston, MA

See all colorectal cancer clinical trials recruiting in Boston — not just this study.

Browse Colorectal Cancer Trials in Boston →

Browse More Trials by Condition

Colorectal Cancer TrialsAll Conditions →

Ready to Join in Boston?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Boston, MA